Our molecule has been newly listed in the pharmacopeia of China and has received marketing approval from NMPA (China) for treating Severe Malignant Airway Obstructions in Non-Small Cell Lung Carcinomas (NSCLC). In clinical studies, our product PTS 302 has successfully demonstrated its safety and Efficacy in treating tumors in airway obstructions and Gongwin Biopharm is confident to provide and introduce this therapeutic approach as a better novel treatment for treating focal malignancies in airways.
PTS intra tumoral injections have shown high selectivity for cancer cells and have minimum damage to healthy cells. It has also shown great results in treating tumors in H & N cancers, Liver cancer, breast cancer and other types. Clinical trials are currently being conducted in Taiwan, China & USA for following indications.
GWB is also applying its core technology to develop formulas for ablating tumors in companion animals in Taiwan. Currently a field trials for treating Melanoma in Canines will start in Dec. 2022
Products
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.- Bone Slices
- Corticosterone EIA
- Dentine Discs
- Bone Slices
- Corticosterone EIA
- Dentine Discs
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.- Bone Slices
- Bone Slices
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.
- Bone Slices
- Corticosterone EIA
- Bone Slices
- Corticosterone EIA